Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - 04-21-2009 RXNIRC Notice of Intent to Issue a Reexam Certificate

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

fs2006

Rank: President [?]

Points: 6748 [?]

Votes: 86 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

04-21-2009 RXNIRC Notice of Intent to Issue a Reexam Certificate

posted on Apr 22, 2009 08:41AM

Claim 29 as amended is Patentable over the prior art of record.The following is an examiner's statment of reasons for patentability and/or confirmation of Claim 29 found patentable in this reexamination proceeding: